Yow-Ming C Wang (Yow-Ming Wang)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 24

Top Topics

Monoclonal Antibody

Drug Administration

Top Venues

Clinical pharmacology and therapeutics

Clinical and translational science

Journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhe Li, Xiulian Du, Shiew Mei Huang, Yow-Ming C Wang
Pharmacokinetics-Bridging Between Autoinjectors and Prefilled Syringes for Subcutaneous Injection: Case Examples Revealing a Knowledge Gap. Clinical pharmacology and therapeutics (2024)
Zhe Li, Xiulian Du, Shiew Mei Huang, Yow-Ming C Wang
Pharmacokinetics-Bridging Between Autoinjectors and Prefilled Syringes for Subcutaneous Injection: Case Examples Revealing a Knowledge Gap. Clinical pharmacology and therapeutics 115 (3) (2024)
Zhe Li, Xiulian Du, Shiew Mei Huang, Yow-Ming C Wang
Pharmacokinetics-Bridging Between Autoinjectors and Prefilled Syringes for Subcutaneous Injection: Case Examples Revealing a Knowledge Gap. Clinical pharmacology and therapeutics 115 (3) (2024)
Yow-Ming C Wang, Ping Ji, Sudharshan Hariharan, Jie Wang, Olanrewaju O Okusanya, Bilal Abuasal, Hao Zhu, Rajanikanth Madabushi, Shiew Mei Huang, Issam Zineh
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins. Clinical pharmacology and therapeutics 115 (3) (2024)
Yow-Ming C Wang, Ping Ji, Sudharshan Hariharan, Jie Wang, Olanrewaju O Okusanya, Bilal Abuasal, Hao Zhu, Rajanikanth Madabushi, Shiew Mei Huang, Issam Zineh
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins. Clinical pharmacology and therapeutics 115 (3) (2024)
Yow-Ming C Wang, Ping Ji, Sudharshan Hariharan, Jie Wang, Olanrewaju O Okusanya, Bilal Abuasal, Hao Zhu, Rajanikanth Madabushi, Shiew Mei Huang, Issam Zineh
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins. Clinical pharmacology and therapeutics 115 (3) (2024)
Yow-Ming C Wang, Ping Ji, Sudharshan Hariharan, Jie Wang, Olanrewaju O Okusanya, Bilal Abuasal, Hao Zhu, Rajanikanth Madabushi, Shiew Mei Huang, Issam Zineh
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins. Clinical pharmacology and therapeutics (2024)
Brianna Eales, Nada A Helal, Olivia Vattelana, Mohamad M Kronfol, Elimika Pfuma Fletcher, Yow-Ming C Wang, Gilbert J Burckart, Jayabharathi Vaidyanathan, Shirley K Seo, Mohamed Ismail Nounou
Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological Products. Journal of clinical pharmacology (2024)
Yow-Ming C Wang, Ping Ji, Sudharshan Hariharan, Jie Wang, Olanrewaju O Okusanya, Bilal Abuasal, Hao Zhu, Rajanikanth Madabushi, Shiew Mei Huang, Issam Zineh
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins. Clinical pharmacology and therapeutics (2024)
Zhe Li, Xiulian Du, Shiew Mei Huang, Yow-Ming C Wang
Pharmacokinetics-Bridging Between Autoinjectors and Prefilled Syringes for Subcutaneous Injection: Case Examples Revealing a Knowledge Gap. Clinical pharmacology and therapeutics 115 (3) (2024)
Yuen Yi Hon, Jie Wang, Henrietta Abodakpi, Anand Balakrishnan, Michael Pacanowski, Sushanta Chakder, Patroula Smpokou, Kathleen Donohue, Yow-Ming C Wang
Dose Selection for Biological Enzyme Replacement Therapy Indicated for Inborn Errors of Metabolism. Clinical and translational science (2023)
Sihem Ait-Oudhia, Yow-Ming C Wang, Anne-Gaelle Dosne, Amit Roy, Jin Y Jin, Jun Shen, Leonid Kagan, Flora T Musuamba, Lucia Zhang, Shinichi Kijima, Marc R Gastonguay, Daniele Ouellet
Challenging the Norm: A Multidisciplinary Perspective on Intravenous to Subcutaneous Bridging Strategies for Biologics. Clinical pharmacology and therapeutics (2023)
Morasa Sheikhy, Sarah J Schrieber, Qin Sun, Victoria Gershuny, Murali K Matta, Jane P F Bai, Xiulian Du, Giri Vegesna, Aanchal Shah, Kristin Prentice, Colleen Nalepinski, Issam Zineh, Yow-Ming C Wang, David G Strauss, Jeffry Florian
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (I) A Randomized Trial with PCSK9 Inhibitors. Clinical pharmacology and therapeutics (2022)
Yow-Ming C Wang, David G Strauss
Advancing Innovations in Biosimilars. Clinical pharmacology and therapeutics 113 (1) (2022)
Paula L Hyland, Lakshmi Manasa S Chekka, Deepti P Samarth, Barry A Rosenzweig, Erica Decker, Esraa G Mohamed, Yan Guo, Murali K Matta, Qin Sun, William Wheeler, Carlos Sanabria, James L Weaver, Sarah J Schrieber, Jeffry Florian, Yow-Ming C Wang, David G Strauss
Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ-1a Biologics. Clinical pharmacology and therapeutics (2022)
David G Strauss, Yow-Ming C Wang, Jeffry Florian, Issam Zineh
Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and Approval. Clinical pharmacology and therapeutics (2022)
Jeffry Florian, Victoria Gershuny, Qin Sun, Sarah J Schrieber, Murali K Matta, Anthony Hazel, Morasa Sheikhy, James L Weaver, Paula L Hyland, Cheng-Hui Hsiao, Giri Vegesna, Ryan DePalma, Aanchal Shah, Kristin Prentice, Carlos Sanabria, Yow-Ming C Wang, David G Strauss
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (III) A Randomized Trial with Interferon Beta-1a Products. Clinical pharmacology and therapeutics (2022)
Jeffry Florian, Qin Sun, Sarah J Schrieber, Richard White, Sophie Shubow, Bernadette E Johnson-Williams, Morasa Sheikhy, Nicholas R Harrison, Valerie J Parker, Yow-Ming C Wang, David G Strauss
Pharmacodynamic Biomarkers for Biosimilar Development and Approval: A Workshop Summary. Clinical pharmacology and therapeutics (2022)
Fang Li, Qin Sun, Shengnan Du, Jeffry Florian, Yaning Wang, Shiew Mei Huang, Issam Zineh, Yow-Ming C Wang
Model-Based Approach to Selecting Pegfilgrastim Dose for Pharmacokinetic and Pharmacodynamic Similarity Studies in Biosimilar Development. Clinical pharmacology and therapeutics (2022)
Victoria Gershuny, Qin Sun, Sarah J Schrieber, Murali K Matta, James L Weaver, Ping Ji, Morasa Sheikhy, Cheng-Hui Hsiao, Giri Vegesna, Aanchal Shah, Kristin Prentice, Jennifer Deering, Yow-Ming C Wang, David G Strauss, Jeffry Florian
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (II) A Randomized Trial with IL-5 Antagonists. Clinical pharmacology and therapeutics (2022)
Sophie Shubow, Qin Sun, Ai Len Nguyen Phan, Dana C Hammell, Maureen Kane, Gary H Lyman, Allan Gibofsky, Gary R Lichtenstein, Zachary Bloomgarden, Raymond K Cross, Sarah Yim, James E Polli, Yow-Ming C Wang
Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary. Clinical pharmacology and therapeutics (2022)
Yow-Ming C Wang, David G Strauss
Advancing Innovations in Biosimilars. Clinical pharmacology and therapeutics 113 (1) (2022)
Jayabharathi Vaidyanathan, Yow-Ming C Wang, Doanh Tran, Shirley K Seo
Leveraging Clinical Pharmacology Data to Assess Biosimilarity and Interchangeability of Insulin Products. Clinical pharmacology and therapeutics (2022)
Dana T Hackel, Theingi M Thway, Shiew Mei Huang, Yow-Ming C Wang
A survey of pharmacokinetic bioanalytical methods in biosimilar biological license applications for the assessment of target and antidrug antibody effects. Bioanalysis 13 (17) (2021)